Vivo Bio Tech Limited has filed its compliance report with BSE Limited regarding the status of physical share transfer requests for March 2026, showing zero activity across all parameters under the SEBI special re-lodgement window.

Regulatory Compliance Report

The report was submitted on April 13, 2026, by Company Secretary A V Kiran in compliance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026. This circular established a special window for the re-lodgement of transfer requests pertaining to physical shares.

Transfer Request Status for March 2026

The detailed status report prepared by Aarthi Consultants Private Limited, the company's registrar and share transfer agent, shows complete absence of physical share transfer activity:

Registrar and Transfer Agent Details

Aarthi Consultants Private Limited serves as the Category I Registrars & Share Transfer Agents for Vivo Bio Tech Limited. The company holds SEBI Registration No. INR000000379 and operates under CIN: U74140TG1992PTC014044. The compliance report was signed by Jagan Mohan Gobburi, Compliance Officer at Aarthi Consultants Private Limited, on April 6, 2026.

SEBI Circular Implementation

The SEBI circular dated January 30, 2026, requires companies to report monthly on the status of physical share transfer re-lodgement requests. This regulatory measure aims to facilitate the transfer of physical shares through a designated special window, with companies required to maintain detailed records and submit regular status updates to stock exchanges.

Vivo Bio Tech Limited has filed its quarterly dematerialization compliance certificate with BSE Limited, demonstrating adherence to regulatory requirements for the first quarter of fiscal year 2027.

Regulatory Compliance Filing

The company submitted the mandatory certificate on April 07, 2026, covering the period from January 01, 2026 to March 31, 2026. This filing fulfills the requirements under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Registrar Confirmation

M/s. Aarthi Consultants Private Limited, serving as the company's Registrar and Transfer Agent, provided the compliance certificate dated April 03, 2026. The registrar confirmed completion of all required dematerialization processes within the regulatory timeframe of 15 days.

Compliance Actions Completed

Aarthi Consultants Private Limited confirmed the following actions were completed during the quarter:

• Securities comprised in dematerialized certificates remain listed on appropriate stock exchanges
• Mutilation and cancellation of physical certificates forwarded by participants
• Substitution of depository name as registered owner in company records
• All processes completed within the mandated 15-day period upon receipt of certificates

Corporate Governance

The filing demonstrates Vivo Bio Tech Limited's commitment to maintaining regulatory compliance and transparent corporate governance practices. The company's systematic approach to dematerialization processes ensures investor protection and market integrity.

The certificate was signed by Compliance Officer Jagan Mohan Gobburi on behalf of Aarthi Consultants Private Limited, which operates as a Category I Registrar and Share Transfer Agent under SEBI Registration Number INR000000379.